1. Home
  2. CXDO vs PEPG Comparison

CXDO vs PEPG Comparison

Compare CXDO & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.26

Market Cap

223.1M

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$3.06

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
PEPG
Founded
1995
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
207.1M
IPO Year
1999
2022

Fundamental Metrics

Financial Performance
Metric
CXDO
PEPG
Price
$6.26
$3.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$9.20
$11.17
AVG Volume (30 Days)
334.4K
1.0M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
25.61
EPS
0.05
N/A
Revenue
$68,167,000.00
N/A
Revenue This Year
$45.26
N/A
Revenue Next Year
$13.31
N/A
P/E Ratio
$128.40
N/A
Revenue Growth
12.05
N/A
52 Week Low
$5.55
$1.17
52 Week High
$11.23
$7.80

Technical Indicators

Market Signals
Indicator
CXDO
PEPG
Relative Strength Index (RSI) 42.33 59.32
Support Level $6.18 $1.47
Resistance Level $6.76 $3.14
Average True Range (ATR) 0.21 0.20
MACD 0.03 -0.01
Stochastic Oscillator 43.33 27.27

Price Performance

Historical Comparison
CXDO
PEPG

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: